Cargando…

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali

BACKGROUND: In 2012, seasonal malaria chemoprevention (SMC) was recommended as policy for malaria control by the World Health Organization (WHO) in areas of highly seasonal malaria transmission across the Sahel sub-region in Africa along with monitoring of drug resistance. We assessed the long-term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahamar, Almahamoudou, Sumner, Kelsey M., Levitt, Brandt, Freedman, Betsy, Traore, Aliou, Barry, Amadou, Issiaka, Djibrilla, Dembele, Adama B., Kanoute, Moussa B., Attaher, Oumar, Diarra, Boubacar N., Sagara, Issaka, Djimde, Abdoulaye, Duffy, Patrick E., Fried, Michal, Taylor, Steve M., Dicko, Alassane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822718/ https://www.ncbi.nlm.nih.gov/pubmed/35135546 http://dx.doi.org/10.1186/s12936-022-04059-z

Ejemplares similares

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial
por: Barry, Amadou, et al.
Publicado: (2018)

Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2017)

Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

Adverse pregnancy outcomes among women presenting at antenatal clinics in Ouélessébougou, Mali
por: Andemel, Naissem, et al.
Publicado: (2020)

Impact of seasonal malaria chemoprevention on hospital admissions and mortality in children under 5 years of age in Ouelessebougou, Mali
por: Issiaka, Djibrilla, et al.
Publicado: (2020)

Age-dependent increase in antibodies that inhibit Plasmodium falciparum adhesion to a subset of endothelial receptors
por: Attaher, Oumar, et al.
Publicado: (2019)

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali
por: Maiga, Hamma, et al.
Publicado: (2016)

Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali
por: Maiga, Hamma, et al.
Publicado: (2015)

Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
por: Stone, Will, et al.
Publicado: (2022)

Host factors that modify Plasmodium falciparum adhesion to endothelial receptors
por: Mahamar, Almahamoudou, et al.
Publicado: (2017)

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali
por: Tekete, Mamadou, et al.
Publicado: (2009)

Pregnancy outcomes in a malaria-exposed Malian cohort of women of child-bearing age
por: Gaoussou, Santara, et al.
Publicado: (2022)

Antibody Levels to Plasmodium falciparum Erythrocyte Membrane Protein 1-DBLγ11 and DBLδ-1 Predict Reduction in Parasite Density
por: Araj, Brittany N., et al.
Publicado: (2021)

Evaluation of the Mercy weight estimation method in Ouelessebougou, Mali
por: Dicko, Alassane, et al.
Publicado: (2014)

Randomized Trial of Artesunate+Amodiaquine, Sulfadoxine-Pyrimethamine+Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania
por: Mutabingwa, Theonest K., et al.
Publicado: (2009)

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa
por: Woodford, John, et al.
Publicado: (2022)

Genome-wide genetic variation and molecular surveillance of drug resistance in Plasmodium falciparum isolates from asymptomatic individuals in Ouélessébougou, Mali
por: Vanheer, Leen N., et al.
Publicado: (2023)

Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial
por: Stone, William, et al.
Publicado: (2022)

Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
por: Dicko, Alassane, et al.
Publicado: (2010)

Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali
por: Kayentao, Kassoum, et al.
Publicado: (2009)

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
por: Dicko, Alassane, et al.
Publicado: (2011)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01(E) vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
por: Chandramohan, Daniel, et al.
Publicado: (2020)

Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes
por: Fried, Michal, et al.
Publicado: (2018)

Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali
por: Diawara, Fatou, et al.
Publicado: (2017)

Molecular markers of resistance to amodiaquine plus sulfadoxine–pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger
por: Grais, Rebecca F., et al.
Publicado: (2018)

Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial
por: Sagara, Issaka, et al.
Publicado: (2009)

The remarkable tenacity of sulfadoxine-pyrimethamine
por: Divala, Titus H, et al.
Publicado: (2019)

Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali
por: Tekete, Mamadou M, et al.
Publicado: (2011)

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali
por: Dicko, Alassane, et al.
Publicado: (2008)

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01(E) Malaria Vaccine( )
por: Sagara, Issaka, et al.
Publicado: (2021)

Monitoring of the Sensitivity In Vivo of Plasmodium falciparum to Artemether-Lumefantrine in Mali
por: Diarra, Modibo, et al.
Publicado: (2021)

Determinants of intermittent preventive treatment with sulfadoxine–pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey
por: Sangho, Oumar, et al.
Publicado: (2021)

Two-Year Scale-Up of Seasonal Malaria Chemoprevention Reduced Malaria Morbidity among Children in the Health District of Koutiala, Mali
por: Maiga, Hamma, et al.
Publicado: (2020)

Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial
por: Taylor, Steve M., et al.
Publicado: (2022)

Evolution of Malaria Incidence in Five Health Districts, in the Context of the Scaling up of Seasonal Malaria Chemoprevention, 2016 to 2018, in Mali
por: Sacko, Aissata, et al.
Publicado: (2021)

Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children
por: Cisse, Badara, et al.
Publicado: (2009)

Repeated Artemisinin-Based Combination Therapies in a Malaria Hyperendemic Area of Mali: Efficacy, Safety, and Public Health Impact
por: Sagara, Issaka, et al.
Publicado: (2012)

Assessment of the Teratogenic Effect of Sulfadoxine-Pyrimethamine on the Chicken Embryo
por: Tari, Rachida Moussa, et al.
Publicado: (2022)

Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance
por: Sundararaman, Sesh A., et al.
Publicado: (2022)

Impact of seasonal RTS,S/AS01(E) vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali
por: Grant, Jane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ggs5hfnu1301tv82npit9ofrca